ARIAD PHARMACEUTICALS INC's ticker is ARIA and the CUSIP is 04033A100. A total of 207 filers reported holding ARIAD PHARMACEUTICALS INC in Q3 2013. The put-call ratio across all filers is 1.65 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2014 | $3,000 | +200.0% | 400 | +100.0% | 0.00% | – |
| Q4 2013 | $1,000 | -75.0% | 200 | 0.0% | 0.00% | – |
| Q3 2013 | $4,000 | -80.0% | 200 | -83.3% | 0.00% | -100.0% |
| Q2 2013 | $20,000 | -9.1% | 1,200 | 0.0% | 0.00% | 0.0% |
| Q1 2013 | $22,000 | -4.3% | 1,200 | 0.0% | 0.00% | 0.0% |
| Q4 2012 | $23,000 | -20.7% | 1,200 | 0.0% | 0.00% | 0.0% |
| Q3 2012 | $29,000 | +45.0% | 1,200 | 0.0% | 0.00% | 0.0% |
| Q2 2012 | $20,000 | +5.3% | 1,200 | 0.0% | 0.00% | 0.0% |
| Q1 2012 | $19,000 | +35.7% | 1,200 | 0.0% | 0.00% | 0.0% |
| Q4 2011 | $14,000 | +55.6% | 1,200 | +20.0% | 0.00% | – |
| Q3 2011 | $9,000 | -66.7% | 1,000 | -58.8% | 0.00% | -100.0% |
| Q2 2011 | $27,000 | +50.0% | 2,425 | 0.0% | 0.00% | 0.0% |
| Q1 2011 | $18,000 | +260.0% | 2,425 | +142.5% | 0.00% | – |
| Q4 2010 | $5,000 | +25.0% | 1,000 | 0.0% | 0.00% | – |
| Q3 2010 | $4,000 | – | 1,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 12,850,000 | $82,111,000 | 18.09% |
| Consonance Capital Management LP | 5,575,742 | $35,629,000 | 5.39% |
| Opaleye Management Inc. | 1,250,000 | $7,988,000 | 4.98% |
| Tamarack Advisers, LP | 1,600,000 | $10,224,000 | 3.58% |
| Camber Capital Management LP | 5,405,235 | $34,539,000 | 2.02% |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 324,636 | $2,074,000 | 1.36% |
| Palo Alto Investors LP | 2,248,317 | $14,367,000 | 1.12% |
| 1492 Capital Management LLC | 202,500 | $1,294,000 | 1.09% |
| Geduld E E | 120,100 | $767,000 | 1.05% |
| JS Capital Management LLC | 868,700 | $5,551,000 | 1.00% |